Bionic pancreas effective at maintaining blood glucose levels in people with type 1 diabetes

A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found.

Related Keywords

United States ,Chicago ,Illinois ,Jill Weissberg Benchell ,Ann Roberth Lurie ,Emily Henderson ,National Institute Of Diabetes ,Study Co ,National Institutes Of Health ,Diabetes Technology ,National Institute ,Kidney Diseases ,National Institutes ,New England Journal ,Study Co Author ,Pediatric Psychologist ,Behavioral Sciences ,Northwestern University Feinberg School ,Diabetes ,Pancreas ,Type 1 Diabetes ,Utomation ,Flood ,Children ,Clinical Trial ,Glucose ,Ormone ,Hospital ,Hypoglycemia ,Insulin ,Kidney ,Medicine ,Research ,